SPONSOR
Vanderbilt-Ingram Cancer Center
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Clonal HematopoiesisRelapsed Myelodysplastic SyndromeRefractory Myelodysplastic SyndromeAcute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
Vanderbilt-Ingram Cancer Center is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Clonal Hematopoiesis, Relapsed Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Vanderbilt-Ingram Cancer Center
How many clinical trials has Vanderbilt-Ingram Cancer Center sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Vanderbilt-Ingram Cancer Center, of which 2 are actively recruiting participants. These trials cover conditions including Clonal Hematopoiesis, Relapsed Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Vanderbilt-Ingram Cancer Center research focus on?
Vanderbilt-Ingram Cancer Center clinical trials span Clonal Hematopoiesis, Relapsed Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Vanderbilt-Ingram Cancer Center clinical trial?
To participate in a Vanderbilt-Ingram Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Vanderbilt-Ingram Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Vanderbilt-Ingram Cancer Center
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology